登录后查看消息通知
搜索
常见问题
消息
登录
首页
/
数据集
/
Supplementary Table S5 from Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function
Supplementary Table S5 from Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function
收藏
Figshare
2023-08-03 更新
2026-04-28 收录
CART细胞代谢调控
肿瘤免疫治疗代谢组学
数据链接：
https://figshare.com/articles/dataset/Supplementary_Table_S5_from_Immunogenetic_Metabolomics_Reveals_Key_Enzymes_That_Modulate_CAR_T-cell_Metabolism_and_Function/23828285
数据链接
链接失效反馈
官方服务：
问题咨询
购买咨询
在线客服
NEW
资源简介：
Supplementary Table S5
应用场景：
创建时间：
2023-08-03
相关数据集
Supplementary Table S7 from Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function
CART细胞代谢调控
代谢组学
Supplementary Table S7
Figshare
2023-08-03 更新
3
0
Supplementary Table S8 from Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function
CART细胞代谢调控
代谢组学
Supplementary Table S8
NIAID Data Ecosystem
2
0
cohort1-47 from Evaluating for Correlations between Specific Metabolites in Patients Receiving First-Line or Second-Line Immunotherapy for Metastatic or Recurrent NSCLC: An Exploratory Study Based on Two Cohorts
肿瘤免疫治疗代谢组学
非小细胞肺癌临床队列研究
original data
NIAID Data Ecosystem
0
0
Supplementary Table S2 from Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function
CART细胞代谢调控
肿瘤代谢组学
Supplementary Table S2
NIAID Data Ecosystem
2
0
The SABR trial and mouse ILDR experiments
肿瘤免疫治疗代谢组学
放疗联合治疗
The SABR trial (NCT02992912): Patients with advanced colorectal cancer (CRC), renal cell carcinoma, non-small cell lung carcinoma (NSCLC) and sarcomas were enrolled in an phase 2 trial. Atezolizumab (
NIAID Data Ecosystem
1
0
© 2023-2026 上海数据发展科技有限责任公司 版权所有
沪ICP备17003045号-15
沪公网安备31010402336585号
热门搜索
社区交流群
科研交流群
商业服务
数据资源
寻源服务
数据采集
标注服务
数据产品
代理销售
数据领域
凭证登记
数据产品
介绍推广
